Literature DB >> 17199108

Mitochondrial rRNA and tRNA and hearing function.

Guangqian Xing1, Zhibin Chen, Xin Cao.   

Abstract

The human ear is a delicate sensory apparatus of hearing for normal communication, and its proper functioning is highly dependent on mitochondrial oxidative phosphorylation. The first mitochondrial point mutation for nonsyndromic and aminoglycoside-induced hearing loss was identified in 1993. Since then a number of inherited mitochondrial mutations have been implicated in hearing loss. Most of the molecular defects responsible for mitochondrial disorder-associated hearing loss are mutations in the 12S rRNA gene and tRNA genes. In this review, after a short description of normal hearing mechanisms and mitochondrial genetics, we outline the recent advances that have been made in the identification of deafness-associated mitochondrial mutations, and discuss how mitochondrial dysfunction contributes to hearing loss.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17199108     DOI: 10.1038/sj.cr.7310124

Source DB:  PubMed          Journal:  Cell Res        ISSN: 1001-0602            Impact factor:   25.617


  15 in total

Review 1.  Genetics of hearing loss: where are we standing now?

Authors:  Hossein Mahboubi; Sami Dwabe; Matthew Fradkin; Virginia Kimonis; Hamid R Djalilian
Journal:  Eur Arch Otorhinolaryngol       Date:  2012-01-05       Impact factor: 2.503

Review 2.  Mitochondrial ribosome assembly in health and disease.

Authors:  Dasmanthie De Silva; Ya-Ting Tu; Alexey Amunts; Flavia Fontanesi; Antoni Barrientos
Journal:  Cell Cycle       Date:  2015-06-01       Impact factor: 4.534

3.  Increased burden of mitochondrial DNA deletions and point mutations in early-onset age-related hearing loss in mitochondrial mutator mice.

Authors:  Mi-Jung Kim; Suraiya Haroon; Guang-Di Chen; Dalian Ding; Jonathan Wanagat; Lijie Liu; Yanping Zhang; Karessa White; Hyo-Jin Park; Chul Han; Kevin Boyd; Isabela Caicedo; Kaitlyn Evans; Paul J Linser; Masaru Tanokura; Tomas Prolla; Richard Salvi; Marc Vermulst; Shinichi Someya
Journal:  Exp Gerontol       Date:  2019-07-22       Impact factor: 4.032

4.  New trends in aminoglycosides use.

Authors:  Marina Y Fosso; Yijia Li; Sylvie Garneau-Tsodikova
Journal:  Medchemcomm       Date:  2014-08-01       Impact factor: 3.597

Review 5.  Physiology and pathophysiology of mitochondrial DNA.

Authors:  Hongzhi Li; Danhui Liu; Jianxin Lu; Yidong Bai
Journal:  Adv Exp Med Biol       Date:  2012       Impact factor: 2.622

Review 6.  Safety and tolerability profile of second-line anti-tuberculosis medications.

Authors:  Geetha Ramachandran; Soumya Swaminathan
Journal:  Drug Saf       Date:  2015-03       Impact factor: 5.606

7.  Noise-induced hearing loss in mice treated with antiretroviral drugs.

Authors:  Devrim Bektas; Glen K Martin; Barden B Stagner; Brenda L Lonsbury-Martin
Journal:  Hear Res       Date:  2008-02-08       Impact factor: 3.208

Review 8.  Mitochondrial translation and beyond: processes implicated in combined oxidative phosphorylation deficiencies.

Authors:  Paulien Smits; Jan Smeitink; Lambert van den Heuvel
Journal:  J Biomed Biotechnol       Date:  2010-04-13

9.  Audiologic and genetic features of the A3243G mtDNA mutation.

Authors:  Richard J Vivero; Xiaomei Ouyang; Yeunjung Grant Kim; Wendy Liu; Lilin Du; Denise Yan; Xue Zhong Liu
Journal:  Genet Test Mol Biomarkers       Date:  2013-03-11

10.  A rapid method for detection of five known mutations associated with aminoglycoside-induced deafness.

Authors:  Soraya Bardien; Hannique Human; Tashneem Harris; Gwynneth Hefke; Rene Veikondis; H Simon Schaaf; Lize van der Merwe; John H Greinwald; Johan Fagan; Greetje de Jong
Journal:  BMC Med Genet       Date:  2009-01-13       Impact factor: 2.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.